These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7201825)

  • 1. [Pharmacokinetics of Morocromen in animals and man (author's transl)].
    Dell HD; Jacobi H; Kamp R; Lorenz D
    Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of fominoben-HCl in the dog and the rabbit (author's transl)].
    Zimmer A
    Arzneimittelforschung; 1979; 29(2):323-8. PubMed ID: 156029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)].
    Hammer R; Bozler G; Jauch R; Koss FW; Hadamovsky H
    Arzneimittelforschung; 1978; 28(5a):899-903. PubMed ID: 581988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
    Wahl D; Förster HJ; Pook KH; Richter I
    Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
    Obermeier K; Niebch G; Thiemer K
    Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man.
    Noda K; Suzuki A; Okui M; Noguchi H; Nishiura M; Nishiura N
    Arzneimittelforschung; 1979; 29(10):1595-600. PubMed ID: 42414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
    Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D
    Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
    Krause W; Kühne G
    Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a new antihypertensive pyrrolyl pyridazinamine (MDL-899) in the rat and the dog.
    Assandri A; Bellasio E; Bernareggi A; Cristina T; Perazzi A; Odasso G
    Arzneimittelforschung; 1985; 35(2):508-13. PubMed ID: 3855234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.
    Vollmer KO; von Hodenberg A; Kölle EU
    Arzneimittelforschung; 1986 May; 36(5):830-9. PubMed ID: 3730018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of cefotaxime in rat, dog and man.
    Macdonald CM; Fromson JM; McDonald A; Dell D; Chamberlain J; Coombes JD
    Arzneimittelforschung; 1984; 34(12):1719-23. PubMed ID: 6099125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G; Obermeier K; Vergin H; Thiemer K
    Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.